发明申请
US20050106640A1 FXIII detection for verifying serum sample and sample size and for detecting dilution
有权
用于验证血清样品和样品量的FXIII检测和检测稀释度
- 专利标题: FXIII detection for verifying serum sample and sample size and for detecting dilution
- 专利标题(中): 用于验证血清样品和样品量的FXIII检测和检测稀释度
-
申请号: US10966650申请日: 2004-10-14
-
公开(公告)号: US20050106640A1公开(公告)日: 2005-05-19
- 发明人: Steven Binder , Jodi Goodrich , Zara Safarian
- 申请人: Steven Binder , Jodi Goodrich , Zara Safarian
- 申请人地址: US CA Hercules
- 专利权人: Bio-Rad Laboratories, Inc., a corporation of the state of Delaware
- 当前专利权人: Bio-Rad Laboratories, Inc., a corporation of the state of Delaware
- 当前专利权人地址: US CA Hercules
- 主分类号: G01N33/53
- IPC分类号: G01N33/53 ; G01N33/96 ; G01N33/567
摘要:
Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.
公开/授权文献
信息查询
IPC分类: